Pressemelding

AmerisourceBergen og Good Neighbor Pharmacy passerer 5 millioner vaksinedoser tildelt gjennom sitt føderale apotekprogram for COVID-19-vaksinasjon

Conshohocken, Pa. (April 4, 2022) – Good Neighbor Pharmacy, AmerisourceBergen’s nationwide network of independent community pharmacies, today announced that it has exceeded 5 million COVID-19 vaccine doses allocated to independent pharmacies across the U.S. This allocation effort is a part of the Federal Retail Pharmacy Program for COVID-19 Vaccination, a collaboration between the Federal Government, U.S. states and territories, and 21 national pharmacy partners, which includes Good Neighbor Pharmacy

With COVID-19 vaccines authorized for people five years and older, independent pharmacies remain an essential healthcare destination in communities, educating and vaccinating eligible individuals against the virus. Pharmacists have helped administer COVID-19 vaccines in communities across the country by hosting clinics and going above and beyond to help those in need, including uninsured populations, long-term care residents, unsheltered individuals and more. Since February of 2021, Good Neighbor Pharmacy has supported more than 1,600 independent community pharmacies in 45 states, Puerto Rico and Guam. 

“We’re incredibly proud of this milestone,” said Jennifer Zilka, President of Good Neighbor Pharmacy. “I’m constantly in awe of what pharmacists have been able to accomplish – from finding ways to be there for their patients during the pandemic to all the education, testing and vaccinations for COVID-19. I think the nation has witnessed the capabilities, value and care pharmacists and their teams can deliver. And I just want to say thank you to all the pharmacists out there. You’re all an inspiration.”

Nearly 52% of pharmacies within AmerisourceBergen and Good Neighbor Pharmacy Federal Retail Pharmacy Program are in socially vulnerable communities, as outlined by the CDC’s Social Vulnerability Index. Nearly 50% of the patients that received a vaccine through Good Neighbor Pharmacy’s program reside in socially vulnerable communities.

Jasmine Chan, Pharmacist at Central Avenue Pharmacy (CAPrx), who has hosted clinics outside of Monterey, Calif. for unsheltered community members and has hiked hills across Monterey County to find and help those living in homeless encampments, added, “As a pharmacist on the front lines, equitable access continues to be a priority for not only vaccines and booster shots, but also tests and treatments. My pharmacy has made it a point to reach out to community members who may face technology or transportation barriers and assist them. For individuals who don’t speak English or are undocumented, we adjusted processes to accommodate them. We also coordinated and operated mobile vaccine clinics for hard-to-reach populations. I know that I’m one of the thousands of independent pharmacists doing this type of work. It has been an honor and privilege to help serve in this capacity.”

For more information on how independent pharmacies across the nation continue to step up in their communities, check out Good Neighbor Pharmacy’s Fearless Pharmacy page: https://www.wearegnp.com/fearless-pharmacy.

About AmerisourceBergen
AmerisourceBergen fosters a positive impact on the health of people and communities around the world by advancing the development and delivery of pharmaceuticals and healthcare products. As a leading global healthcare company, with a foundation in pharmaceutical distribution and solutions for manufacturers, pharmacies and providers, we create unparalleled access, efficiency and reliability for human and animal health. Our 42,000 global team members power our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #8 on the Fortune 500 with more than $200 billion in annual revenue. Learn more at www.amerisourcebergen.com

Pressemelding

IntrinsiQ Specialty Solutions Expands Data Capabilities, Empowering Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

oktober 16, 2025

Medieuttalelse

Cencora vil støtte kommersiell lansering av Precigens nye immunterapi i USA

september 24, 2025

Medieomtale

ThoughtSpot 2025 fremhever Cencoras forpliktelse til å fremme fremtiden til apotek og sikre tilgang til medisiner

august 27, 2025

Mediekontakter

Trenger du hjelp, eller har du spørsmål?  Send oss en melding, så kommer vi tilbake til deg snart.

Cencora.com tilbyr automatiserte oversettelser for å hjelpe deg med å lese nettstedet på andre språk enn engelsk. Mye arbeid er lagt ned i disse oversettelsene for å gjøre dem nøyaktige, men ingen automatisert oversettelse er perfekt, og slike oversettelser er heller ikke ment å erstatte menneskelige oversettere. Disse oversettelsene leveres som en tjeneste til brukere av Cencora.com og leveres «som de er». Det gis ingen garanti av noe slag, verken uttrykt eller underforstått, med hensyn til nøyaktigheten, påliteligheten eller riktigheten av noen av disse oversettelsene som er gjort fra engelsk til andre språk. Det kan hende at noen typer innhold (som bilder, videoer, Flash osv.) er unøyaktig oversatt på grunn av begrensningene i oversettelsesprogramvaren.

Eventuelle avvik eller forskjeller som oppstår ved oversettelse av dette innholdet fra engelsk til et annet språk, er ikke bindende og har ingen juridisk virkning for samsvar, håndhevelse eller andre formål.  Kontakt oss dersom du oppdager feil. Se den engelske versjonen av siden dersom du er i tvil om hvorvidt informasjonen i disse oversettelsene er nøyaktig.